Effects of Neoadjuvant Intraperitoneal/Systemic Chemotherapy (Bidirectional Chemotherapy) for the Treatment of Patients with Peritoneal Metastasis from Gastric Cancer

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left" colspan="4">Wash cytology after NIPS</td></tr><tr class="thead"><td align="left">Wash cytology before NIPS</td><td align="center">Negative</td><td align="center">Positive</td><td align="center">Total</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">Negative</td><td align="center">27</td><td align="center">1</td><td align="center">28</td></tr><tr><td align="left">Positive</td><td align="center">47</td><td align="center">21</td><td align="center">68 (70.8%)</td></tr><tr><td align="left" colspan="4"><hr/></td></tr><tr><td align="left">74</td><td align="center">22 (22.9%)</td><td align="center">96</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Changes of peritoneal lavage cytology before and after NIPS.

International Journal of Surgical Oncology

tab2

Table 2

Table 2: Effects of Neoadjuvant Intraperitoneal/Systemic Chemotherapy (Bidirectional Chemotherapy) for the Treatment of Patients with Peritoneal Metastasis from Gastric Cancer 

Table 2 | Effects of Neoadjuvant Intraperitoneal/Systemic Chemotherapy (Bidirectional Chemotherapy) for the Treatment of Patients with Peritoneal Metastasis from Gastric Cancer 